Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma
Molecular Medicine Reports · 2025
DOI: 10.3892/mmr.2025.13708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Pia S Zeiner und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, D‑60596 Frankfurt, Germany. Hauptthemen laut MEDLINE: Microglia, Glioblastoma, TOR Serine-Threonine Kinases, Macrophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Glioma‑associated microglia/macrophages (GAM) constitute the predominant immune cell population in glioblastoma (GB). Both GB cells and GAM exhibit upregulated mTOR signaling. The present study aimed to investigate the effects of pharmacological mTOR inhibition (mTORi) specifically on GAM. The effects of mTORi on signal transduction, cell growth and viability were analyzed in immortalized microglia cell lines. Additionally, a comprehensive analysis of the GAM phenotype was conducted, including whole transcriptome analyses and cytokine profiling. Effects were investigated in a tumor cell/GAM co‑culture model under mTORi with rapamycin or torin2 or treatment with temozolomide, the standard chemotherapy agent for patients with GB. In the in vitro model, mTORi had significant effects on central biological functions of GAM, resulting in reduced proliferation and oxygen consumption. Additionally, treatment with mTORi induced a pro‑inflammatory phenotype in microglia cell lines. These findings demonstrate the relevance of mTOR signaling on GAM biology. Moreover, they provide rationales for therapeutic interventions targeting mTOR signaling specifically in GAM as a potential novel treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Senckenberg Institute of Neurooncology, University Hospital, Goethe University Frankfurt, D‑60596 Frankfurt, Germany.
- Georg‑Speyer‑Haus, Institute for Tumor Biology and Experimental Therapy, D‑60596 Frankfurt, Germany.
- Frankfurt Cancer Institute, Goethe University Frankfurt, D‑60596 Frankfurt am Main, Germany.
- Institute for Medical Virology, University Hospital, Goethe University Frankfurt, D‑60596 Frankfurt, Germany.
- Institute of Neurology (Edinger‑Institute), University Hospital, Goethe University Frankfurt, D‑60528 Frankfurt, Germany.
Zitieren
APA
Zeiner, P. S., Schulz, M., Schomber, J., Weinem, J. B., Lorenz, N. I., Sauer, B., Roller, B., Weber, K. J., Luger, A. L., Berger, A., Plate, K. H., Sevenich, L., Steinbach, J. P., Mosa, M. H., Harter, P. N., & Ronellenfitsch, M. W. (2025). Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13708
Vancouver
Zeiner PS, Schulz M, Schomber J, Weinem JB, Lorenz NI, Sauer B, et al. Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13708
BibTeX
@article{Zeiner2025,
author = {Zeiner, Pia S and Schulz, Michael and Schomber, Jana and Weinem, Jan-Béla and Lorenz, Nadja I and Sauer, Benedikt and Roller, Bastian and Weber, Katharina J and Luger, Anna-Luisa and Berger, Annemarie and Plate, Karl H and Sevenich, Lisa and Steinbach, Joachim P and Mosa, Mohammed H and Harter, Patrick N and Ronellenfitsch, Michael W},
title = {Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma},
journal = {Molecular Medicine Reports},
year = {2025},
doi = {10.3892/mmr.2025.13708}
}
EUVIMED